from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2089c/pepE

LFCtreatmentdescriptionclass of inhibitor

0.410

Amikacinug/mL Amikacintranslation

0.010

Cap5-10ug/mL Capreomycintranslation

0.514

Rox10-50 ug/mL Roxithromycintranslation

-0.260

SM2-5 ug/mL Streptomycintranslation

0.295

Tet5-10 ug/mL Tetracyclinetranslation

-0.422

Rif0.2-5ug/mL Rifampicintranscription

0.617

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.546

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.965

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.471

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.105

Clofazimine10-13 ug/mL Clofaziminerespiration

0.054

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.279

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.297

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.653

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.285

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.132

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.997

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.415

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.081

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.603

KCN5-20 ug/mL Potassium cyaniderespiration

-0.172

NaN30.2-2 mM Sodium aziderespiration

1.052

Nigericin50 uM Nigericinrespiration

0.236

TRC10-150 ug/mL Triclosanrespiration

2.117

TRZ10-25 ug/mL Thioridazinerespiration

1.227

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.667

menadione6-10 ug/mL Menadionerespiration

-0.163

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.408

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.044

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.069

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.398

NRP_1Non-replicating persistence stage 1dosRassociated

-0.196

Amp0.2mg/mL AmpicillincellWall

-0.325

Cephalexin20-100 ug/mL CephalexincellWall

0.394

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.459

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.405

EMB10-20 ug/mL EthambutolcellWall

0.186

Eta12-40 ug/mL EthionamidecellWall

-0.075

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.085

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.002

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.301

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.198

BZA0.12 mg/mL BenzamidearomaticAmides

-0.557

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.392

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.164

H2O24 mM hydrogen peroxideDNAdamaging

0.023

Levo10 ug/mL LevofloxacinDNAdamaging

-0.186

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.336

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.060

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.040

UVUV-irradiationDNAdamaging

0.015

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.322

Antimycin12.5-50 ug/mL Antimycin A?

-0.490

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.221

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.232

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.250

PA8240.2-2 ug/mL PA-824?

-0.393

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.495

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.346

Verapamil50 uM Verapamil?

-0.123

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.306

methoxatin10-20 ug/mL Methoxatin?